AI-generated question list for blood cancer patients
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This trial tests if an AI tool can help you create a personalized list of questions about your cancer treatment to ask your doctor at your next visit. It is for patients with lymphoma or multiple myeloma who get regular infusion therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have lymphoma or multiple myeloma (a type of blood cancer).
- You have a follow-up visit at a specific clinic in the next month.
- You receive infusion or injection-based treatment every 1 to 4 weeks to manage or cure your cancer.
- You are between 18 and 99 years old.
- You can make your own medical decisions (no legal representative needed).
- You can read and communicate in English and use email.
- You do not have vision problems that stop you from reading on a screen or paper.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if an artificial intelligence (AI) program can help people with blood cancer learn about their condition and treatment. The goal is to see if AI-assisted education improves their understanding and care.
This study tests whether an AI (computer system) can help improve leukemia and related blood cancer diagnoses. You may be able to help if your doctor is already evaluating you for a possible blood disorder and your sample is high enough quality for testing.
This trial tests if a special tool can help adults aged 60 and older who are newly visiting a blood cancer or bone marrow transplant clinic understand their options and make decisions that fit their needs.
This trial uses an AI system to help match people with certain cancer types and specific tumor test results (like gene or protein markers) to relevant clinical trials. It may help you and your doctor find studies that fit your cancer biology faster.
This trial tests whether an AI-based tool can help choose the best treatment for older adults with large B-cell lymphoma who are not fit for standard chemotherapy. It compares a personalized AI strategy with a standard two-drug regimen.
This study tests whether a computer-guided treatment plan can work as well as or better than the standard chemo-immunotherapy for large B-cell lymphoma. It uses a special test after the first cycle to decide who needs a more aggressive approach.
Hear when a new Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.